JP2017509585A5 - - Google Patents

Download PDF

Info

Publication number
JP2017509585A5
JP2017509585A5 JP2016541595A JP2016541595A JP2017509585A5 JP 2017509585 A5 JP2017509585 A5 JP 2017509585A5 JP 2016541595 A JP2016541595 A JP 2016541595A JP 2016541595 A JP2016541595 A JP 2016541595A JP 2017509585 A5 JP2017509585 A5 JP 2017509585A5
Authority
JP
Japan
Prior art keywords
formula
salt
compound
providing
crystal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016541595A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017509585A (ja
JP6425727B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/071319 external-priority patent/WO2015100145A1/en
Publication of JP2017509585A publication Critical patent/JP2017509585A/ja
Publication of JP2017509585A5 publication Critical patent/JP2017509585A5/ja
Application granted granted Critical
Publication of JP6425727B2 publication Critical patent/JP6425727B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016541595A 2013-12-23 2014-12-18 大環状hcv ns3阻害トリペプチド Active JP6425727B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361920446P 2013-12-23 2013-12-23
US61/920,446 2013-12-23
PCT/US2014/071319 WO2015100145A1 (en) 2013-12-23 2014-12-18 Synthesis of a macrocyclic hcv ns3 inhibiting tripeptide

Publications (3)

Publication Number Publication Date
JP2017509585A JP2017509585A (ja) 2017-04-06
JP2017509585A5 true JP2017509585A5 (https=) 2018-01-18
JP6425727B2 JP6425727B2 (ja) 2018-11-21

Family

ID=52278856

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016541595A Active JP6425727B2 (ja) 2013-12-23 2014-12-18 大環状hcv ns3阻害トリペプチド

Country Status (20)

Country Link
US (2) US9440991B2 (https=)
EP (1) EP3087085B1 (https=)
JP (1) JP6425727B2 (https=)
KR (1) KR102366697B1 (https=)
CN (3) CN105849118B (https=)
AR (1) AR098959A1 (https=)
AU (1) AU2014370125B2 (https=)
CA (1) CA2934537C (https=)
EA (1) EA201691031A1 (https=)
ES (1) ES2724460T3 (https=)
IL (1) IL246064A0 (https=)
MX (1) MX2016008452A (https=)
NZ (1) NZ720745A (https=)
PL (1) PL3087085T3 (https=)
PT (1) PT3087085T (https=)
SG (1) SG11201604482QA (https=)
SI (1) SI3087085T1 (https=)
TR (1) TR201906413T4 (https=)
TW (3) TWI671292B (https=)
WO (1) WO2015100145A1 (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA029281B1 (ru) 2013-07-30 2018-03-30 Джилид Коннектикут, Инк. Полиморф ингибиторов syk
CA2919522C (en) * 2013-07-30 2019-02-26 Gilead Connecticut, Inc. Formulation of syk inhibitors
TWI662037B (zh) 2013-12-23 2019-06-11 美商基利科學股份有限公司 脾酪胺酸激酶抑制劑
PT3087085T (pt) 2013-12-23 2019-06-04 Gilead Sciences Inc Síntese de um tripéptido macrocíclico inibidor de ns3 de hcv
US9809576B1 (en) 2014-07-18 2017-11-07 Abbvie Inc. Synthetic route to anti-viral agents
US9809534B1 (en) * 2014-07-21 2017-11-07 Abbvie Inc. Difluoroalkylcyclopropyl amino acids and esters, and syntheses thereof
US10059969B1 (en) 2014-10-03 2018-08-28 Abbvie Inc. Process for the preparation of (S)-2-amino-non-8-enoic acid
US10316338B1 (en) 2015-01-30 2019-06-11 Abb Vie Inc. Enzymatic process for the preparation of (1S,2R)-2-(difluoromethyl)-1-(propoxycarbonyl)cyclopropanecarboxylic acid
US10450291B2 (en) 2015-06-29 2019-10-22 Central Glass Company, Limited Method for producing fluorine-containing cyclopropane carboxylic acid compound
EP3577100A4 (en) 2017-02-01 2021-03-10 Abbvie Inc. ENZYMATIC PROCESS FOR THE PRODUCTION OF (±) -2- (DIFLUOROMETHYL) -1- (ALCOXYCARBONYL) -CYCLOPROPANECARBONIC ACID AND (±) -2- (VINYL) -1- (ALCOXYCARBONYLURE) -CYCLOPROPANEC
CN107739319A (zh) * 2017-10-31 2018-02-27 上海同昌生物医药科技有限公司 一种Glecaprevir合成中间体及其胺盐的制备方法
WO2019084740A1 (zh) * 2017-10-31 2019-05-09 上海同昌生物医药科技有限公司 一种Glecaprevir合成中间体及其胺盐的制备方法
CN107827748A (zh) * 2017-11-14 2018-03-23 安徽华胜医药科技有限公司 一种乙酸2‑烯丙基环丙酯消旋体的合成方法
KR102519417B1 (ko) 2018-11-28 2023-04-10 삼성디스플레이 주식회사 스트레처블 표시 장치
CN113950479A (zh) 2019-02-22 2022-01-18 克洛诺斯生物股份有限公司 作为syk抑制剂的缩合吡嗪的固体形式

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20060109937A (ko) * 2003-12-15 2006-10-23 니뽄 다바코 산교 가부시키가이샤 N-치환-n-술포닐아미노시클로프로판 화합물 및 그의약제학적 용도
CL2008003384A1 (es) 2007-11-14 2009-12-11 Enanta Pharm Inc Compuestos derivados de quinoxalina macrocíclica, inhibidores de serina proteasa; composicion farmaceutica que los comprende; y su uso en el tratamiento de la hepatitis c.
US8211891B2 (en) 2008-04-30 2012-07-03 Enanta Pharmaceuticals, Inc. Difluoromethyl-containing macrocyclic compounds as hepatitis C virus inhibitors
EA019327B1 (ru) * 2008-07-22 2014-02-28 Мерк Шарп Энд Домэ Корп. Макроциклическое хиноксалиновое соединение в качестве ингибитора протеазы вгс ns3
US8283310B2 (en) 2008-12-15 2012-10-09 Bristol-Myers Squibb Company Hepatitis C virus inhibitors
EP2289880A1 (en) * 2009-07-08 2011-03-02 Bayer CropScience AG 2-Pyridinylcyclopropylbenzamide fungicides
US20130178413A1 (en) * 2010-09-21 2013-07-11 John A. McCauley Hcv ns3 protease inhibitors
SG188618A1 (en) * 2010-09-21 2013-04-30 Enanta Pharm Inc Macrocyclic proline derived hcv serine protease inhibitors
UY33775A (es) * 2010-12-10 2012-07-31 Gilead Sciences Inc Inhibidores macrocíclicos de virus flaviviridae, composiciones farmacéuticas que los comprenden y sus usos
UA119315C2 (uk) 2012-07-03 2019-06-10 Гіліад Фармассет Елелсі Інгібітори вірусу гепатиту с
WO2015095430A1 (en) * 2013-12-20 2015-06-25 Merck Sharp & Dohme Corp. Methods and intermediates for the preparation of macrolactams
WO2015100144A1 (en) * 2013-12-23 2015-07-02 Gilead Sciences, Inc. Crystalline forms of a macrocyclic hcv ns3 inhibiting tripeptide
PT3087085T (pt) 2013-12-23 2019-06-04 Gilead Sciences Inc Síntese de um tripéptido macrocíclico inibidor de ns3 de hcv

Similar Documents

Publication Publication Date Title
JP2017509585A5 (https=)
JP2016520672A5 (https=)
ME02861B (me) Postupak za pripremu treprostinila i njegovih derivata
JP2010043124A5 (https=)
EP3056486A3 (en) Process for preparing intermediates for antiviral compounds
JP2011126894A5 (https=)
WO2012004396A3 (en) Process of preparing a thrombin specific inhibitor
JP2010530373A5 (https=)
AR098959A1 (es) Síntesis de un compuesto antiviral e intermediarios de la misma
JO3263B1 (ar) مشتق إندان سلفاميد جديد
AR088296A1 (es) Citramida de rasagilina, proceso de preparación y composicion farmaceutica
GB2504237A (en) Extraction of carboxylic acids with tin compounds
RU2017145357A (ru) Пролекарство на основе фосфамида монобензилового сложного эфира тенофовира, способ его получения и применение
EP2736860A4 (en) METHOD FOR THE PRODUCTION OF AROMATIC HYDROCARBONS FROM BYPRODUCTS OF AROMATIC CARBOXYLIC ACID AND / OR METHOD FOR THE PRODUCTION OF AN AROMATIC CARBOXYLIC ALKYL REAGER
JP2014506185A5 (https=)
WO2012099734A3 (en) Improved process for preparation of low molecular weight molybdenum succinimide complexes
JP2016523246A5 (https=)
WO2013128419A3 (en) Pharmaceutical compositions comprising boronic acid compounds
SA112330457B1 (ar) مشتقات فينيل- ايزواوكسازول وعملية تحضيرها
EA201490383A1 (ru) Способ получения ситаглиптина и его фармацевтически приемлемых солей
MX360161B (es) Proceso para preparar compuestos antiviricos.
EP2684859A4 (en) PROCESS FOR PREPARING FLUOROUS OLEFINS WITH SUBSTITUENTS FROM ORGANIC GROUPS
AR081267A1 (es) Procedimiento de obtencion de la forma cristalina a del febuxostat
JP2016517904A5 (https=)
EA201790659A1 (ru) Способ получения сложных эфиров карбоновых кислот в присутствии титансодержащего катализатора